Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: J Immunol. 2020 May 18;205(1):261–271. doi: 10.4049/jimmunol.1901472

Fig. 6. Virus resistance is induced in ISG15-deficient cells following longer periods of IFN-α pre-treatment.

Fig. 6

(a) Experimental workflow. (b) Cells were treated 1000 IU/ml IFN-α in 6-well plates for the indicated times prior to infection. Pre-treated cells were infected with rPIV5-mCherry (MOI 10) for 48 h and mCherry fluorescence was measured using an IncuCyte ZOOM. Background fluorescence from mock-infected wells was subtracted. Data are representative to two independent experiments.